Cat.#: ACPP-1718
| Despition | ASRGL1 Human Recombinant |
| SIZE | 2 µg |
| Purity | > 90.0% (SDS-PAGE) |
| Form | Sterile Filtered colorless solution. |
| Storage | Store at 4°C for 2-4 weeks. |
| Shipping | Shipped at 4°C |
| Cat.# | Name | Size | Price |
|---|---|---|---|
| ACPP-1341 | Pax2 Blocking Peptide (AC1341) | 250 µg | inquiry |
| ACPP-1203 | ADCY8 Blocking Peptide (AC1203) | 250 µg | inquiry |
| ACPP-1071 | Visfatin Blocking Peptide (AC1071) | 250 µg | inquiry |
| ACPP-1490 | SOX10 Blocking Peptide (AC1490) | 250 µg | inquiry |
| ACPP-1369 | Parkin Blocking Peptide (AC1369) | 250 µg | inquiry |
| ACPP-1477 | Mouse I TAC Protein (AC1477) | 5 µg | inquiry |
| ACPP-1011 | Recombinant Human FGF1 Protein (AC1011) | 50 µg | inquiry |
| ACPP-1306 | FGFR2 Blocking Peptide (AC1306) | 250 µg | inquiry |
| ACPP-1715 | Mouse Acrp30 Protein, HEK (AC1715) | 2 µg | inquiry |
| ACPP-1759 | Rat CDNF Protein (AC1759) | 5 µg | inquiry |
Ace Therapeutics is a global leading provider of stroke research services. We are committed to accelerating progress in stroke research and drug development.